Company intelligence / Profile preview

Jeff Golini

Ownership: Private
Employees: ~135
Development stage: Commercial

Overview

All American Pharmaceutical develops and manufactures patented nutritional ingredients and dietary supplements. Some products have undergone clinical studies in both the U.S. and abroad. Kre-Celazine® has received FDA Orphan Drug designation for Juvenile Rheumatoid Arthritis. Other products like Karbolyn® have been studied in pre-diabetic populations[4].

Therapeutic areas: OtherEndocrinologyRheumatology
Modalities: Small molecule (nutritional compounds, e.g., creatine derivatives)Biologic (some protein-based or carbohydrate-based supplement ingredients)
Industry: Biotech

Partnerships

Montana Department of Agriculture/Farmers partnership for pulse crop development[4]

Beyond the preview

Go deeper on Jeff Golini.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jeff Golini.

Explore the full profile